Every 10 minutes someone dies from melanoma. Almost everyone should survive but often diagnosis comes too late. Skin Analytics makes screening of melanoma at home possible with a specially designed lens and phone app. Backed by Telefonica and Angels, the company has an existing partnership with Vitality UK, and is aiming for its new product to be a Class II medical device used by individuals and medical professionals.
Financial data drawn from last filed accounts don't necessarily reflect current trading activity. Financials provided by Company Check.
2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | |
---|---|---|---|---|---|---|---|---|
Turnover | - | - | - | - | - | - | - | - |
Cash | £20.07k | £59.47k | £0 | £479.99k | £358.98k | £0 | £0 | £0 |
Increase in Cash | - | - | - | - | - | - | - | - |
2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | |
---|---|---|---|---|---|---|---|---|
Audit Fees | £0 | £0 | £0 | £0 | £0 | £0 | £0 | £0 |
Cost of Sales | - | - | - | - | - | - | - | - |
Depreciation | £0 | - | - | - | - | - | - | - |
Directors Emoluments | - | - | - | - | - | - | - | - |
Dividends | - | - | - | - | - | - | - | - |
Export | - | - | - | - | - | - | - | - |
Gross Profit | - | - | - | - | - | - | - | - |
Interest Payments | - | - | - | - | - | - | - | - |
Operating Profit | - | - | - | - | - | - | - | - |
Pretax Profit | - | - | - | - | - | - | - | - |
Profit after Tax | - | - | - | - | - | - | - | - |
Retained Profit | - | - | - | - | - | - | - | - |
Taxation | - | - | - | - | - | - | - | - |
Turnover | - | - | - | - | - | - | - | - |
Wages & Salaries | - | - | - | - | - | - | - | - |
2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | |
---|---|---|---|---|---|---|---|---|
Intangible Assets | £0 | £0 | £0 | £0 | £0 | £0 | £0 | £0 |
Bank Loans & Overdrafts | £0 | £0 | £0 | £0 | £0 | £0 | £0 | £0 |
Cash | £20.07k | £59.47k | £0 | £479.99k | £358.98k | £0 | £0 | £0 |
Miscellaneous Current Assets | £0 | £0 | £429 | £0 | £0 | £0 | £0 | £0 |
Miscellaneous Current Liabilities | £0 | £0 | £0 | £0 | £0 | £0 | £0 | £0 |
Other Debtors | £0 | £0 | £0 | £0 | £0 | £0 | £0 | £0 |
Other Long Term Finance | £0 | £0 | £0 | £0 | £0 | £0 | £0 | £0 |
Other Short Term Finance | £0 | £0 | £0 | £0 | £0 | £0 | £0 | £0 |
Stock | £0 | £0 | £0 | £0 | £0 | £0 | £0 | £0 |
Tangible Accounts | £0 | £18 | £401 | £1.93k | £8k | £2.58k | £4.34k | £4.35k |
Total Current Assets | £20.07k | £59.47k | £1.83k | £488.68k | £365.41k | £373.33k | £1.29m | £693.98k |
Total Current Liabilities | £87 | £0 | £20k | £255 | £6.91k | £29.35k | £38.79k | £655.94k |
Total Fixed Assets | £0 | £18 | £401 | £1.93k | £8k | £2.58k | £4.34k | £4.35k |
Total Long Term Finance | £0 | £0 | £6.15k | £0 | £0 | £0 | £0 | £0 |
Trade Creditors | £87 | £0 | £20k | £255 | £6.91k | £29.35k | £38.79k | £655.94k |
Trade Debtors | £0 | £0 | £1.4k | £8.69k | £6.43k | £373.33k | £1.29m | £693.98k |
2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | |
---|---|---|---|---|---|---|---|---|
Profit & Loss Account Reserve | £-64.02k | £-70.08k | £-23.93k | £490.36k | £366.5k | £346.55k | £1.26m | £42.38k |
Called up share capital | £84k | £1 | £0 | £0 | £0 | £0 | £0 | £0 |
Revaluation Reserve | £0 | £0 | £0 | £0 | £0 | £0 | £0 | £0 |
Shareholder Funds | £19.98k | £59.48k | £-23.93k | £490.36k | £366.5k | £346.55k | £1.26m | £42.38k |
Sundry Reserves | £0 | £129.56k | £0 | £0 | £0 | £0 | £0 | £0 |
2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | |
---|---|---|---|---|---|---|---|---|
Increase in Cash | - | - | - | - | - | - | - | - |
Net Cash Flow Before Financing | £0 | £0 | £0 | £0 | £0 | £0 | £0 | £0 |
Net Cash Flow From Financing | - | - | - | - | - | - | - | - |
Net Cash Flow From Operations | - | - | - | - | - | - | - | - |
2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | |
---|---|---|---|---|---|---|---|---|
Net Assets | £19.98k | £59.48k | £-23.93k | £490.36k | £366.5k | £346.55k | £1.26m | £42.38k |
Net Worth | £19.98k | £59.48k | £-23.93k | £490.36k | £366.5k | £346.55k | £1.26m | £42.38k |
Total Assets | £20.07k | £59.48k | £2.23k | £490.61k | £373.41k | £375.9k | £1.29m | £698.32k |
Total Liabilities | £87 | £0 | £26.15k | £255 | £6.91k | £29.35k | £38.79k | £655.94k |
Working Capital | £19.98k | £59.47k | £-18.18k | £488.43k | £358.5k | £343.97k | £1.25m | £38.04k |
2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | |
---|---|---|---|---|---|---|---|---|
Creditor Days | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Current Debt Ratio | 0% | 0% | -0.83% | 0% | 0.01% | 0.08% | 0.03% | 15.47% |
Current Ratio | 230.69% | 0% | 0.09% | 1.92k% | 52.88% | 12.72% | 33.26% | 1.06% |
Debtor Days | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Equity In Percentage | 99.6% | 100% | -1.07k% | 99.9% | 98.1% | 92.2% | 97% | 6.1% |
Gearing | 0% | 0% | -25.7% | 0% | 0% | 0% | 0% | 0% |
Liquidity Ratio Or Acid Test | 230.68% | 0% | 0.09% | 1.92k% | 52.88% | 12.71% | 33.25% | 1.05% |
Pre Tax Profit Margin | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Return On Capital Employed | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Return On Net Assets Employed | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Return On Total Assets Employed | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Sales Or Net Working Capital | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Stock Turnover Ratio | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Total Debt Ratio | 0% | 0% | -1.09% | 0% | 0.01% | 0.08% | 0.03% | 15.47% |